S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NOV NOV Inc

14.52

-0.30 (-2.02%)

Dec 17 2024 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

NOV (NYSE:NOV)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more NOV Charts.

NOV (NYSE:NOV)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more NOV Charts.

NOV Inc News

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 17 December 2024 (15 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 16 December 2024 (2 days ago) • Edgar (US Regulatory)

NOV Appoints Chris Kendall to the Board of Directors
Monday 16 December 2024 (2 days ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (4 weeks ago) • Edgar (US Regulatory)

NOV Declares Regular Quarterly Dividend
Thursday 14 November 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

More NOV Inc News Articles

Tonix Pharmaceuticals

TPT Global Tech (CE)

GBT Technologies (PK)

Bioelectronics (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Moon Equity (PK)

NioCorp Developments

Decentral Life (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions